Jing Wang

50PUBLICATIONS
475CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Apr 21, 2026
Dual Inhibition of TRIP13 and Aurora A Induces Mitotic DNA Damage and Concurrent Pyroptotic-Apoptotic Cell Death in Rb-Deficient Cancer Cells.

|Feb 25, 2026
Loss of miR-29a/b1 Cluster Reprograms the Tumor Microenvironment and Contributes to Immunosuppression in Lung Cancer.

Natalie K Horvat, Myritney Saint-Cloud, Raihaanah Bint Abdullah Muslim

|Feb 09, 2026
Antigen presentation requirements for effective cDC1-based cancer immunotherapy.

Josué E Pineda, Tomoyuki Minowa, Li Shen

|Jan 22, 2026
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction.

Linjie Luo, Yan Wang, Tuyen Bui

|Jan 10, 2026
Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma Models.

Yifei Wang, Zhongting Zhang, Caterina Longo

|Dec 24, 2025
Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts.

Xiao-Ting Jiang, Mei-Kuang Chen, Jiwang Lee

Pageof 9

Frequent Collaborators

11 joint publications

Lixia Diao

10 joint publications

John V Heymach

10 joint publications

Don L Gibbons

10 joint publications

Li Shen